comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 01:31:52 - browse：8841

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Disclosing genetic information: not as worrisome as once feared

leisure time

WSS

#NeedHerScience: shining a light on gender disparities in medicine

1 dead, 9 hurt in July 4th fireworks explosion

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

NASA releases new images of 'fingerprint

Leon Gautier, last member of French D

explore

comprehensive

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

ChatGPT in medicine: STAT answers readers' burning questions

CDC concerned about possible undetected monkeypox spread in U.K.

Medical leaders decry Supreme Court decision on affirmative action

EU climate chief is concerned over the expansion of the coal industry in China

ChatGPT in medicine: STAT answers readers' burning questions

Gene therapy has helped boys walk. Can scientists keep it that way?

The high cost of giving birth even with insurance

Churchill Downs extends trainer Bob Baffert's ban through 2024

leisure time

3 hurdles to bringing medical devices to the U.S. market

Russians and Belarusians back at Wimbledon as war in Ukraine continues

#NeedHerScience: shining a light on gender disparities in medicine

#NeedHerScience: shining a light on gender disparities in medicine

NASA releases new images of 'fingerprint

EU climate chief is concerned over the expansion of the coal industry in China

leisure time

leisure time

hotspot

explore